Literature DB >> 17978836

Pathophysiological adaptations to walking and cycling in primary pulmonary hypertension.

G Valli1, C D Vizza, P Onorati, R Badagliacca, R Ciuffa, R Poscia, F Brandimarte, F Fedele, P Serra, P Palange.   

Abstract

Exercise tolerance inversely correlates with the severity of the disease in patients with idiopathic pulmonary arterial hypertension (IPAH). Cycling and walking protocols are commonly utilized in the evaluation of exercise intolerance in IPAH, but little information exists on possible differences in ventilatory and gas exchange adaptations to these exercise modalities. In a group of patients with moderate to severe IPAH (n = 13), we studied the ventilatory, cardiovascular and gas exchange adaptations to maximal incremental walking (W) and maximal incremental cycling (C). During W, compared to C, the ventilatory equivalents for CO(2) output (V'(E)/V'CO(2)) were significantly higher either expressed as the rate of increment (56 +/- 5 vs. 45 +/- 3; P < 0.0001) or as the absolute values at anaerobic threshold (AT) and at peak exercise. At AT, the increase in V'(E)/V'CO(2) during W was associated with a significant lower value of end-tidal carbon dioxide. At peak W, compared to peak C, dyspnea sensation was higher and arterial oxygen saturation (SpO(2)) was lower (87 +/- 2 vs. 91 +/- 2, P < 0.001). In patients with IPAH the physiologic information obtained with W are different from those obtained with C. Tolerance to W exercise is limited by high ventilatory response and dyspnea sensation. W should be used to assess the degree of lung gas exchange inefficiency and arterial O(2) desaturation during exercise.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978836     DOI: 10.1007/s00421-007-0600-y

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  23 in total

1.  On-line computer analysis and breath-by-breath graphical display of exercise function tests.

Authors:  W L Beaver; K Wasserman; B J Whipp
Journal:  J Appl Physiol       Date:  1973-01       Impact factor: 3.531

2.  Exercise pathophysiology in patients with primary pulmonary hypertension.

Authors:  X G Sun; J E Hansen; R J Oudiz; K Wasserman
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

3.  Gas exchange responses to continuous incremental cycle ergometry exercise in primary pulmonary hypertension in humans.

Authors:  M S Riley; J Pórszász; M P Engelen; B H Brundage; K Wasserman
Journal:  Eur J Appl Physiol       Date:  2000-09       Impact factor: 3.078

4.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

Authors:  G H Guyatt; M J Sullivan; P J Thompson; E L Fallen; S O Pugsley; D W Taylor; L B Berman
Journal:  Can Med Assoc J       Date:  1985-04-15       Impact factor: 8.262

5.  Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Authors:  Michael McGoon; David Gutterman; Virginia Steen; Robin Barst; Douglas C McCrory; Terry A Fortin; James E Loyd
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

6.  Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.

Authors:  Roland Wensel; Christian F Opitz; Stefan D Anker; Jörg Winkler; Gert Höffken; Franz X Kleber; Rakesh Sharma; Manfred Hummel; Roland Hetzer; Ralf Ewert
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

7.  Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease.

Authors:  D R Dantzker; J S Bower
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

8.  Development of a shuttle walking test of disability in patients with chronic airways obstruction.

Authors:  S J Singh; M D Morgan; S Scott; D Walters; A E Hardman
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

9.  Pulmonary gas exchange during exercise in patients with chronic obliterative pulmonary hypertension.

Authors:  D R Dantzker; G E D'Alonzo; J S Bower; K Popat; B J Crevey
Journal:  Am Rev Respir Dis       Date:  1984-09

10.  Continuous distributions of ventilation-perfusion ratios in normal subjects breathing air and 100 per cent O2.

Authors:  P D Wagner; R B Laravuso; R R Uhl; J B West
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

View more
  4 in total

Review 1.  Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

2.  Sex-specific cardiopulmonary exercise testing parameters as predictors in patients with idiopathic pulmonary arterial hypertension.

Authors:  Ping Yuan; Hui-Juan Ni; Tian-Xiang Chen; Bigyan Pudasaini; Rong Jiang; Hui Liu; Qin-Hua Zhao; Lan Wang; Su-Gang Gong; Jin-Ming Liu
Journal:  Hypertens Res       Date:  2017-06-01       Impact factor: 3.872

3.  EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.

Authors:  Marco Guazzi; Volker Adams; Viviane Conraads; Martin Halle; Alessandro Mezzani; Luc Vanhees; Ross Arena; Gerald F Fletcher; Daniel E Forman; Dalane W Kitzman; Carl J Lavie; Jonathan Myers
Journal:  Circulation       Date:  2012-09-05       Impact factor: 29.690

4.  Performance of Heart Failure Patients with Severely Reduced Ejection Fraction during Cardiopulmonary Exercise Testing on Treadmill and Cycle Ergometer; Similarities and Differences.

Authors:  Reza Mazaheri; Mohammad Sadeghian; Mahshid Nazarieh; David Niederseer; Christian Schmied
Journal:  Int J Environ Res Public Health       Date:  2021-12-08       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.